Ibuprom Effect Żel (Ibuprofen)

The ibuprofen in the gel reversibly inhibits COX‑1 and COX‑2 enzymes in the skin and underlying tissues, decreasing prostaglandin production. Lower prostaglandin levels reduce inflammation and blunt pain signals, providing localized analgesic and anti‑inflammatory effects.

The appropriate amount and frequency of application are determined by the prescribing healthcare professional based on the severity of symptoms, the size of the affected area, and individual patient factors. Patients should follow the prescriber’s instructions and the product label.

Safety data for topical ibuprofen during pregnancy and lactation are limited. Healthcare providers generally advise caution and may recommend alternative treatments, especially in the first trimester or while breastfeeding, unless the benefits outweigh potential risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Topical ibuprofen delivers the active ingredient directly to the site of pain, resulting in lower systemic exposure compared with oral tablets. This can reduce the risk of gastrointestinal side effects, but the depth of penetration is limited to superficial tissues, making it unsuitable for deep or systemic pain.

Store the gel at room temperature, ideally below 25 °C, in its original packaging. Keep it away from moisture, direct sunlight, and extreme heat. Ensure the cap is tightly closed to maintain product stability.

Apply a thin layer of the gel to clean, dry, intact skin over the affected area. Gently massage until fully absorbed, typically 2–3 times daily or as directed by a healthcare professional. Do not cover the area with occlusive dressings unless instructed.

Serious risks include severe allergic reactions such as anaphylaxis, widespread dermatitis, and rare systemic toxicity if significant absorption occurs. Users should discontinue use and seek immediate medical attention if they experience signs of a severe reaction, such as swelling, difficulty breathing, or extensive skin blistering.

Individuals with known hypersensitivity to ibuprofen or any component of the gel, those with open wounds or broken skin at the intended application site, and patients taking systemic NSAIDs or anticoagulants without medical guidance should avoid using this product.